Grant: Discovery Grants Program - Individual
McGill University
$34,000.00
Coxsackie and adenovirus receptor (CAR): functions of a novel adhesion molecule
FY 2012-13
Summary
The Coxsackie and adenovirus receptor (CAR) is a novel member of the immunoglobulin superfamily of adhesion molecules. As its name implies, it was first identified as the high affinity receptor for adenovirus type 5, the most commonly used adenoviral vector for gene transfer. My laboratory's interest in CAR stems from our routine use adenovirus (Ad) vectors for gene transfer to muscle, nervous system and tumour cells. Thus, we have been interested in determining the expression pattern of CAR and means of modulating its expression, as well as examining its function in these tissues.
CAR expression is regulated developmentally and in a tissue-specific manner. Highest levels of CAR expression are observed in prenatal and neonatal tissues. This pattern of expression suggests CAR could play a role in the growth, migration or differentiation of embryonic or neonatal tissues. Such a role for CAR is further supported by the observation of loss of CAR expression in several types of cancer.
Our long term objective is to understand how an adhesion molecule such as CAR transmits extracellular cues into intracellular signals. We have concentrated on two biological systems, tumour cells and neurons. In both cell types, CAR plays crucial roles in cell migration. In tumour cells, CAR expression leads to inhibition of migration and invasion while in neurons, CAR expression promotes process extension (neurite outgrowth). We have shown CAR can undergo metalloprotease-mediated shedding of its extracellular domain, followed by cleavage through the gamma-secretase complex to produce an intracellular cytoplasmic fragment, thus generating potentially important signalling molecules. CAR expression is highest in the developing nervous system, making primary neuronal cultures and mouse embryonic nervous system development the ideal experimental models to study CAR function. Our specific objectives are to:1) determine the functional relevance of the proteolytic processing of CAR; 2) determine whether CAR's intracellular cytoplasmic domain plays a signaling role; 3) study the function of CAR in the developing nervous system.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
386391-2012
Name nom
Nalbantoglu, Josephine
Department département
Neurology and Neurosurgery
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Partie
1
Nb partie
5
Application title
Coxsackie and adenovirus receptor (CAR): functions of a novel adhesion molecule
Keyword
NSERC
Application summary
The Coxsackie and adenovirus receptor (CAR) is a novel member of the immunoglobulin superfamily of adhesion molecules. As its name implies, it was first identified as the high affinity receptor for adenovirus type 5, the most commonly used adenoviral vector for gene transfer. My laboratory's interest in CAR stems from our routine use adenovirus (Ad) vectors for gene transfer to muscle, nervous system and tumour cells. Thus, we have been interested in determining the expression pattern of CAR and means of modulating its expression, as well as examining its function in these tissues.
CAR expression is regulated developmentally and in a tissue-specific manner. Highest levels of CAR expression are observed in prenatal and neonatal tissues. This pattern of expression suggests CAR could play a role in the growth, migration or differentiation of embryonic or neonatal tissues. Such a role for CAR is further supported by the observation of loss of CAR expression in several types of cancer.
Our long term objective is to understand how an adhesion molecule such as CAR transmits extracellular cues into intracellular signals. We have concentrated on two biological systems, tumour cells and neurons. In both cell types, CAR plays crucial roles in cell migration. In tumour cells, CAR expression leads to inhibition of migration and invasion while in neurons, CAR expression promotes process extension (neurite outgrowth). We have shown CAR can undergo metalloprotease-mediated shedding of its extracellular domain, followed by cleavage through the gamma-secretase complex to produce an intracellular cytoplasmic fragment, thus generating potentially important signalling molecules. CAR expression is highest in the developing nervous system, making primary neuronal cultures and mouse embryonic nervous system development the ideal experimental models to study CAR function. Our specific objectives are to:1) determine the functional relevance of the proteolytic processing of CAR; 2) determine whether CAR's intracellular cytoplasmic domain plays a signaling role; 3) study the function of CAR in the developing nervous system.